Search results
Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next?
Zacks via Yahoo Singapore Finance· 4 hours agoHims & Hers (HIMS) is enhancing its offerings and expanding the breadth of health and wellness...
Nestlé and other companies are trying to stake their claims as weight loss drug experts. They’re not
CNN Business via Yahoo Singapore Finance· 2 days agoAs the use of popular weight loss and diabetes drugs like Wegovy and Ozempic skyrockets, consumer...
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is...
People via Yahoo News Singapore· 1 day agoWhile some recent reports have highlighted the potential for drugs that are classified as...
Ozempic is changing the way people eat. Snack companies are paying close attention
CBC via Yahoo Singapore Finance· 1 day agoRaegan Sather says her appetite has completely changed — and so has her approach to grocery shopping...
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Yahoo Finance· 3 days agoNovo also said that the cost of both of its GLP-1s has decreased 40% since launch. "Unfortunately,...
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo Singapore Finance· 1 day agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
The Top Country With Most Scientists per Capita in the World
Insider Monkey via Yahoo Singapore Finance· 6 days agoWe recently compiled a list of the 10 Countries With the Most Scientists per Capita in the World and...
Why Is DexCom, Inc. (DXCM) One Of The Best Growth Stocks for Billionaire Ray Dalio?
Insider Monkey via Yahoo Singapore Finance· 7 days agoWe recently compiled a list of the 10 Best Growth Stocks To Buy Now According To Billionaire Ray...
Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
Insider Monkey via Yahoo Singapore Finance· 2 days agoArtisan Partners, an investment management company, released its “Artisan Global Equity Fund” first...
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Zacks via Yahoo Singapore Finance· 2 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...